Scientists investigated whether gilteritinib, a selective FLT3 inhibitor, could enhance graft-versus-leukemia effects against FLT3 internal tandem duplication mutant transfected Ba/F3 leukemia in mice.
[Bone Marrow Transplantation]
Sorry, but the selected Zotpress account can't be found.
